• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2005 Fiscal Year Final Research Report Summary

Research on the effects of tamoxifen in rats with estrogen- and progesterone-receptor negative ovarian cancer.

Research Project

Project/Area Number 14571595
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Obstetrics and gynecology
Research InstitutionIwate Medical University

Principal Investigator

SUGIYAMA Toru  Iwate Medical University, School of Medicine, Professor, 医学部, 教授 (40162903)

Co-Investigator(Kenkyū-buntansha) IZUTSU Toshihiko  Iwate Medical University, School of Medicine, Professor, 医学部, 教授 (00103739)
YOSHIZAKI Akira  Iwate Medical University, School of Medicine, Lecturer, 医学部, 助手 (40200969)
SHOJI Tadahiro  Iwate Medical University, School of Medicine, Research Associate, 医学部, 助手 (00337148)
OTA Shunichiro  Kurume University, School of Medicine, Research Associate, 医学部, 助手 (40289476)
Project Period (FY) 2002 – 2005
KeywordsTamoxifen / apoptosis / cell cycle / ovarian cancer / anti-tumor effect
Research Abstract

The effects of tamoxifen (TAM) on the growth and cell cycle kinetics in an estrogen- and progesterone-receptor negative ovarian cancer in rats were evaluated. Although no macroscopic reducting effect of TAM on tumors was found, proliferation and replacement of connective tissue and the expansion of central necrosis was observed histologically. The administration of TAM (2.0mg/kg) caused a tendency to decrease S-phase cells and increase G0/G1-phase cells. These findings indicate that TAM might inhibit DNA syntheses. TAM significantly increased apoptosis cell in the Sub-G1 region on DNA cytograms in a dose-dependent manner. TAM is therefore thought to have a potentially inhibitory effect on the growth of ovarian cancer.

  • Research Products

    (25 results)

All 2005 2004 2003 2002

All Journal Article (25 results)

  • [Journal Article] 新薬展望2005 子宮悪性腫瘍治療薬.2005

    • Author(s)
      杉山徹 他
    • Journal Title

      医薬ジャーナル 41・S-1

      Pages: 181-188

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] 子宮頚癌・体癌における腫瘍マーカーとその利用の仕方.2005

    • Author(s)
      杉山徹 他
    • Journal Title

      成人病と生活習慣病 35・6

      Pages: 663-667

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Clinical characteristics of mucinous adenocarcinoma of the ovary2005

    • Author(s)
      Sugiyama T, et al.
    • Journal Title

      J Clin Oncol 23・16s

      Pages: 469s

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Phase I study of paclitaxel (TXL), doxorubicin (ADM) and carboplatin (CBDCA) combination therapy (TAC) in patients with high-risk and recurrent endometrial cancer.2005

    • Author(s)
      Sugiyama T, et al.
    • Journal Title

      J Clin Oncol 23・16s

      Pages: 475s

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] A Phase I/II study of weekly intraperitoneal (IP) paclitaxel (PAC) with monthly intravenous (IV) carboplatin (CBDCA) for optimal debulked epithelial ovarian cancer (EOC) with peritoneal desease (PED)2005

    • Author(s)
      Sugiyama T, et al.
    • Journal Title

      J Clin Oncol 23・16s

      Pages: 484s

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Clinical characteristics of clear cell adenocarcinoma of the ovary-Japan Clear Cell Carcinoma Study Group-.2005

    • Author(s)
      Sugiyama T, et al.
    • Journal Title

      J Clin Oncol 23・16s

      Pages: 484s

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] 「研究成果報告書概要(和文)」より2005

    • Author(s)
      Sugiyama T, et al.
    • Journal Title

      J Clin Oncol 23・16s

      Pages: 479s

  • [Journal Article] Clinical characteristics of mucinous adenocarcinoma of the ovary.2005

    • Author(s)
      Shimada M, Kigawa J, Nishimura R, Suzuki M, Kita T, Sugiyama T, Hiura M, Kaku T, Tsuda H, Terakawa M.
    • Journal Title

      J Chin Oncol 23

      Pages: 469s(#5061)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Phase I study of paclitaxel (TXL), doxorubicin (ADM) and carboplatin (CBDCA) combination therapy (TAC) in patients with high-risk and recurrent endometrial cancer.2005

    • Author(s)
      Sugiyama T, Omi H, Kigawa J, Hatae M, Suzuki M, Tsuda H.
    • Journal Title

      J Chin Oncol 23

      Pages: 475s(#5084)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] A phase I/II study of weekly intraperitoneal (IP) paclitaxel (PAC) with monthly intravenous (IV) carboplatin (CBDCA) for optimal debulked epithelial ovarian cancer (EOC) with peritoneal desease (PED).2005

    • Author(s)
      Takeuchi S, Terai Y, Yamaguchi H, Yamabe S, Ueda M, Ueki M, Maruo T, Sugiyama T
    • Journal Title

      J Clin Oncol 23

      Pages: 484s(#5120)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Clinical characteristics of clear cell adenocarcinoma of the ovary-Japan Clear Cell Carcinoma Study Group-.2005

    • Author(s)
      Takano M, Kita T, Kikuchi Y, Yaegashi N, Kuzuya K, Tsuda H, Suzuki M, Kigawa J, Takeuchi S, Sugiyama T.
    • Journal Title

      J Chin Oncol 23

      Pages: 484s(#5123)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Phase II study of ironotecan plus oral etoposide in patients with platinum and taxane-resistant ovarian cancer.2005

    • Author(s)
      Nishio S, Sugiyama T, Shoji T, Kitagawa R, Ushijima K, Kamura T.
    • Journal Title

      J Chin Oncol 23

      Pages: 479s(#5099)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Vaccination with pre-designated or evidence-based peptides for patients with recurrent gynecologic cancers.2004

    • Author(s)
      Tsuda N, Mochizuki K, Harada M, Sukehiro A, Kawano Koichiro, Yaniada A, Ushijima K, Sugiyama T, Nishida T, Yamada H, Itoh K, Kamura T.
    • Journal Title

      J Immunother 27

      Pages: 60-72

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Clinicopathologic study of 56 patients with endometrial cancer during or after adjuvant tamoxifen use for their breast cancers.2004

    • Author(s)
      Hachisuga T, Saito T, Kigawa J, Ohwada M, Yamazawa K, Yasue A, Iwasaka T, Sugiyama T, Kita T, Nagai N.
    • Journal Title

      Gynecol Oncol 95

      Pages: 139-144

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Weekly 1-h paclitaxel infusion in patients with recurrent endometrial cancer : a preliminary study.2003

    • Author(s)
      Nishio S, Ota S, Sugiyama T, Matsuo G, Kawagoe H, Kumagai S, Ushijima K, Nishida T, Kamura T.
    • Journal Title

      Int J Clin Oncol 8

      Pages: 45-48

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Japanese ovarian trials : focus on irinotecan.2003

    • Author(s)
      Sugiyama T, Yakushiji M, Ochiai K, Noda K.
    • Journal Title

      ONCOLOGY 17

      Pages: 29-33

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Irinotecan (CPT-11) and cisplatin as first-line chemotherapy for advanced ovarian cancer.2002

    • Author(s)
      Sugiyama T, Yakushiji M, Kamura T, et al.
    • Journal Title

      Oncology 63(1)

      Pages: 16-22

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Polymorphisms of UDP-glucuronosyltransferase and pharmacokinetics of irinotecan.2002

    • Author(s)
      Ando Y, Ueoka H, Sugiyama T, et al.
    • Journal Title

      Ther Drug Monit 24

      Pages: 111-116

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary.2002

    • Author(s)
      Itamochi H, Junzo K, Sugiyama T, et al.
    • Journal Title

      Obstet Gynecol 100

      Pages: 281-287

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy.2002

    • Author(s)
      Kanamori Y, Kigawa J, Sugiyama T, et al.
    • Journal Title

      Int J Cancer 100

      Pages: 686-689

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Chemosensitivity of clear cell carcinoma of the ovary.2002

    • Author(s)
      Kigawa J, Itamochi H, Sugiyama T, Kikuchi Y, Suzuki M, Terakawa N.
    • Journal Title

      Recent Res Devel Cancer

      Pages: 493-506

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Advances in chemotherapy for ovarian cancer and uterine cervical cancer-Forcusing on irinotecan (CPT-11)-Res.2002

    • Author(s)
      Sugiyama T, Yakushiji M, Kamura T, et al.
    • Journal Title

      Adv.in Cancer 2

      Pages: 87-96

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Clinical Assessment of neoadjuvant chemotherapy an interval cytoreductive surgery for unressectable advanced ovarian cancer.2002

    • Author(s)
      Ushijima K, Ota S, Sugiyama T, et al.
    • Journal Title

      Int Surg 87

      Pages: 185-190

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Prognosis of patients with operable stage IB cervical cancer not undergoing class III radical hysterectomy.2002

    • Author(s)
      Ishikawa H, Fujiwara K, Mikami Y, Kohno I, Shinozuka T, Yoshida N, Nishida M, Aoki Y, Miyagi Y, Sugiyama T, Kigawa J.
    • Journal Title

      J Clin Oncol 21

      Pages: 171b(#2503)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Glycogen levels in human ovarian clear cell adenocarcinoma in relation to chemosensitivity and cellular growth.2002

    • Author(s)
      Kiyozuka Y, Adachi S, Itoh K, Itani Y, Yamada T, Sugiyama T, Tsubura A.
    • Journal Title

      J Clin Oncol 21

      Pages: 449a(#1792)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2007-12-13  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi